This inventor holds 1 USPTO granted patent. Top assignees: Betagene, Inc., The University of Texas System. Active years: 1999.
Company Filing History:
1 out of 4 
1 out of 5,630 
Years Active: 1999
Title: Thomas C Becker: Innovator in Hexokinase Inhibition
Introduction
Thomas C Becker is a notable inventor based in Carrollton, TX (US). He has made significant contributions to the field of biochemistry, particularly in the area of hexokinase inhibition. His innovative work has implications for various therapeutic applications.
Latest Patents
Becker holds 1 patent for his invention titled "Methods and compositions for inhibiting hexokinase." This patent discloses compositions and methods aimed at inhibiting hexokinase enzymes in mammalian cells. The invention specifically provides proteins that stimulate the production of trehalose-6-phosphate and their respective genes. It also includes hexokinase-specific ribozymes and genes encoding such constructs. Additionally, the patent describes agents that competitively reduce hexokinase activity, including inactive hexokinases and fragments that retain mitochondrial binding functions. The invention outlines various methods of using cells with reduced hexokinase activity, both in vitro and in vivo.
Career Highlights
Throughout his career, Thomas C Becker has worked with several organizations, including Betagene, Inc. and the University of Texas System. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research.
Collaborations
Some of Becker's notable coworkers include He-Ping Han and John E Wilson. Their collaborative efforts have contributed to advancements in the understanding of hexokinase and its role in cellular metabolism.
Conclusion
Thomas C Becker's innovative work in inhibiting hexokinase enzymes showcases his dedication to advancing biochemistry. His contributions have the potential to impact therapeutic strategies in the future.